Better Medicine

What Better Medicine does

Better Medicine OÜ is an Estonian medical technology company founded in 2020 in Tartu that develops AI-powered radiology diagnostics software for cancer detection on CT scans. The platform, branded BMVision, applies a multi-organ approach — covering kidney, lung, and an announced roadmap of liver, pancreas, lymph nodes, and bones — to automated lesion detection, classification, segmentation, and quantification, with BMVision Kidney holding CE Class IIa certification under EU MDR (described as the world's first MDR-certified kidney cancer AI) and BMVision Lung trained on 1,200+ patient datasets. Supporting products include BMViewer, a custom radiology viewer with integrated AI findings; BMGateway, which handles DICOM/PACS integration and de-identification with AWS, Google Cloud, Azure, and SFTP compatibility; and iMeasure, a semi-automated lesion measurement tool for reducing inter-observer variability.

Name

Better Medicine

Legal name

Better Medicine OÜ

Website

https://bettermedicine.ai

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Better Medicine builds CE-certified AI software that detects, classifies, and measures cancer lesions on CT scans, selling to hospitals, radiology departments, AI platforms, and — via Image Analysis Group — oncology clinical trial sponsors, primarily in Europe.

Ownership category

akta.pro rank

Product category

Medical Imaging AI / Radiology Diagnostics Software

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Radiology Reporting, Dictation & Structured Reporting (HLACALAF)

Keywords

• AI radiology diagnostics
• Cancer detection software
• Medical imaging AI
• Radiology workflow automation
• Clinical trial imaging

Headquarters

HQ city

Tartu

HQ country

Estonia

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. AI Diagnostics Software Licensing: Better Medicine licenses its AI-powered radiology diagnostics software (BMVision, BMViewer, BMGateway) to healthcare providers, hospitals, radiology departments, and clinical research organizations. Revenue is generated through software licensing agreements, likely with subscription or per-use pricing models for medical device software.
2. Clinical Trial Imaging Services: Through partnership with Image Analysis Group, Better Medicine provides AI-powered tumor assessment technology integrated into clinical trial workflows for biotech and pharma sponsors, enabling accelerated oncology drug development.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Better Medicine develops and licenses AI-powered radiology diagnostic software that performs automated detection, classification, and quantification of cancer lesions on CT scans across multiple organs including kidney and lung. Its flagship BMVision platform integrates with PACS systems and DICOM viewers to assist radiologists with cancer screening, lesion measurement, and automated reporting. The suite includes BMVision Kidney (CE-certified as a Class IIa medical device), BMVision Lung, BMViewer (custom radiology viewer), BMGateway (data management), and iMeasure (semi-automated lesion measurement).

Product overview

Better Medicine offers a modular AI-powered radiology diagnostics platform centered on BMVision, the world's first clinically validated multi-organ cancer detection solution. The platform follows a platform-plus-modules architecture: BMVision serves as the core AI engine with certified organ-specific modules for kidney (BMVision Kidney) and lung (BMVision Lung), plus upcoming models for liver, pancreas, lymph nodes, and bones. Supporting the AI models are three complementary products: BMViewer provides a custom-built radiology viewer with integrated AI tooling, BMGateway handles automated medical data management and PACS integration with de-identification workflows, and iMeasure delivers semi-automated lesion measurement across all organs. The integrated suite enables radiologists to detect, classify, quantify, and track lesions from a single scan while automating reporting workflows.

Differentiator

Problem solved

Functional benefit

Brands

• BMVision: Multi-organ radiology AI software for full-body cancer detection, including kidney, lung, and upcoming organs (liver, pancreas, lymph nodes, bones).
• BMViewer
• BMGateway

Products and services

• BMVision Full-body AI platform providing multi-organ cancer detection across kidney, lung, and upcoming organs (liver, pancreas, lymph nodes, bones). Detects, classifies, and measures lesions on CT scans with automated 3D segmentation and classification into benign or malignant categories. Designed for radiologists in clinical diagnostic workflows.
• BMVision Kidney World's first and only clinically validated and MDR-certified kidney cancer AI solution for automated detection, classification, and quantification of renal lesions on CT scans. Achieves 99.2% sensitivity in detecting patients with kidney cancer and reduces lesion detection disagreement among radiologists by 34.3%.
• BMVision Lung AI lung cancer detection solution enhancing radiologists' performance with 91.6% sensitivity in lung nodule detection, automated nodule classification, quantification, and monitoring. Supports LUNG-RADS 2022 criteria for standardized assessment and management categorization with Volume Doubling Time estimation.
• BMViewer Custom-built medical imaging viewer designed by radiologists for clinical research. Integrates AI findings, high-quality DICOM image rendering, automated reporting, advanced annotation tools, and lesion measurement capabilities for radiology departments and clinical research workflows.
• BMGateway AI-driven medical data management software for clinical workflow integration. Enables automated patient scan selection, de-identification and pseudonymisation of patient data with envelope encryption, and customisable data export to DICOM nodes and cloud providers including AWS, Google Cloud, and Microsoft Azure.

Quantifiable outcome

• 99.2% sensitivity in detecting patients with kidney cancer when radiologists use BMVision
• +5 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Image Analysis Group (IAG)coreTechnology or Integration · 12 December 2025Strategic partnership to integrate Better Medicine's AI-powered tumor assessment technology into IAG's proprietary DYNAMIKA platform for oncology clinical trials. The integration enables automated tumor identification, measurement, and tracking across CT scans, reducing central read turnaround times and imaging costs while maintaining regulatory-grade quality for biotech and pharma sponsors.
• Latitude59minorGTM or Marketing Partner · 20 May 2025Better Medicine presented at Estonia's prominent startup and technology conference Latitude59 (May 20-22), expressing interest in partnering with India and accessing its market. The conference facilitates networking between Estonian startups and international investors and partners.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Aidoc: Aidoc is a leading AI radiology platform offering a suite of FDA-cleared algorithms across multiple body regions and use cases (CT triage, stroke, PE, etc.), directly competing with Better Medicine's multi-organ CT cancer detection strategy and AI-platform marketplace model.
• Annalise.ai: Annalise.ai provides comprehensive multi-finding AI for chest and other CT/X-ray studies with broad abnormality detection, directly overlapping with BMVision's full-body, multi-organ approach and competing for the same hospital AI buyer.
• Qure.ai: Qure.ai builds AI for medical imaging across CT, MRI, and X-ray for head, chest, and musculoskeletal use cases, overlapping with Better Medicine's CT-based lesion detection, classification, and quantification capabilities on a global commercial scale.
• Lunit: Lunit develops radiology AI (notably Lunit INSIGHT for chest and mammography) with FDA-cleared and CE-marked products, competing head-to-head with BMVision Lung in lung nodule detection and with broader cancer-detection portfolios.
• Aidence (DeepHealth): Aidence, now part of DeepHealth (a RadNet subsidiary), focuses on AI for lung nodule detection and management on CT, directly competing with BMVision Lung and sharing a similar European origin and clinical workflow positioning.
• Viz.ai: Viz.ai offers a portfolio of FDA-cleared radiology AI workflows (notably stroke and cardiac) integrated into a platform with care coordination features, paralleling Better Medicine's platform approach of AI modules + viewer + workflow integration.
• Riverain Technologies: Riverain Technologies builds AI for chest CT and X-ray focused on lung nodule and oncology detection, overlapping directly with BMVision Lung's indication and CE/FDA regulatory positioning.

Emerging players

• Arterys: Arterys provides cloud-native medical imaging AI platform with multi-organ clinical apps and developer tools, comparable to Better Medicine's BMGateway/BMViewer integration plus AI-model approach in the oncology imaging space.

Others

• Deepc: Deepc is an AI radiology platform and marketplace partner that lists certified third-party AI algorithms (including Better Medicine's kidney cancer AI) on its platform; it is a channel partner rather than a direct product competitor.
• CARPL: CARPL is a radiology AI marketplace and integration platform that hosts certified third-party AI vendors including Better Medicine's modules, functioning as a distribution and validation partner rather than a head-to-head product competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/better-medicine-ai

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Better Medicine